Cargando…

Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems

The use of natural compounds is becoming increasingly popular among patients, and there is a renewed interest among scientists in nature-based bioactive agents. Traditionally, herbal drugs can be taken directly in the form of teas/decoctions/infusions or as standardized extracts. However, the disadv...

Descripción completa

Detalles Bibliográficos
Autores principales: Jampilek, Josef, Kralova, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781429/
https://www.ncbi.nlm.nih.gov/pubmed/36559176
http://dx.doi.org/10.3390/pharmaceutics14122681
_version_ 1784857072107520000
author Jampilek, Josef
Kralova, Katarina
author_facet Jampilek, Josef
Kralova, Katarina
author_sort Jampilek, Josef
collection PubMed
description The use of natural compounds is becoming increasingly popular among patients, and there is a renewed interest among scientists in nature-based bioactive agents. Traditionally, herbal drugs can be taken directly in the form of teas/decoctions/infusions or as standardized extracts. However, the disadvantages of natural compounds, especially essential oils, are their instability, limited bioavailability, volatility, and often irritant/allergenic potential. However, these active substances can be stabilized by encapsulation and administered in the form of nanoparticles. This brief overview summarizes the latest results of the application of nanoemulsions, liposomes, solid lipid nanoparticles, and nanostructured lipid carriers used as drug delivery systems of herbal essential oils or used directly for their individual secondary metabolites applicable in cancer therapy. Although the discussed bioactive agents are not typical compounds used as anticancer agents, after inclusion into the aforesaid formulations improving their stability and bioavailability and/or therapeutic profile, they indicated anti-tumor activity and became interesting agents with cancer treatment potential. In addition, co-encapsulation of essential oils with synthetic anticancer drugs into nanoformulations with the aim to achieve synergistic effect in chemotherapy is discussed.
format Online
Article
Text
id pubmed-9781429
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97814292022-12-24 Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems Jampilek, Josef Kralova, Katarina Pharmaceutics Review The use of natural compounds is becoming increasingly popular among patients, and there is a renewed interest among scientists in nature-based bioactive agents. Traditionally, herbal drugs can be taken directly in the form of teas/decoctions/infusions or as standardized extracts. However, the disadvantages of natural compounds, especially essential oils, are their instability, limited bioavailability, volatility, and often irritant/allergenic potential. However, these active substances can be stabilized by encapsulation and administered in the form of nanoparticles. This brief overview summarizes the latest results of the application of nanoemulsions, liposomes, solid lipid nanoparticles, and nanostructured lipid carriers used as drug delivery systems of herbal essential oils or used directly for their individual secondary metabolites applicable in cancer therapy. Although the discussed bioactive agents are not typical compounds used as anticancer agents, after inclusion into the aforesaid formulations improving their stability and bioavailability and/or therapeutic profile, they indicated anti-tumor activity and became interesting agents with cancer treatment potential. In addition, co-encapsulation of essential oils with synthetic anticancer drugs into nanoformulations with the aim to achieve synergistic effect in chemotherapy is discussed. MDPI 2022-12-01 /pmc/articles/PMC9781429/ /pubmed/36559176 http://dx.doi.org/10.3390/pharmaceutics14122681 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jampilek, Josef
Kralova, Katarina
Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
title Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
title_full Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
title_fullStr Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
title_full_unstemmed Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
title_short Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
title_sort anticancer applications of essential oils formulated into lipid-based delivery nanosystems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781429/
https://www.ncbi.nlm.nih.gov/pubmed/36559176
http://dx.doi.org/10.3390/pharmaceutics14122681
work_keys_str_mv AT jampilekjosef anticancerapplicationsofessentialoilsformulatedintolipidbaseddeliverynanosystems
AT kralovakatarina anticancerapplicationsofessentialoilsformulatedintolipidbaseddeliverynanosystems